Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.08)
# 3,836
Out of 5,149 analysts
81
Total ratings
33.33%
Success rate
-14.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Equal-Weight | $8 → $6 | $5.24 | +14.50% | 4 | Feb 26, 2026 | |
| CTEV Claritev | Maintains: Equal-Weight | $33 → $30 | $17.57 | +70.75% | 2 | Feb 24, 2026 | |
| WAY Waystar Holding | Maintains: Overweight | $41 → $36 | $26.44 | +36.18% | 2 | Feb 19, 2026 | |
| DOCS Doximity | Maintains: Overweight | $55 → $45 | $26.25 | +71.43% | 14 | Feb 6, 2026 | |
| PHR Phreesia | Initiates: Overweight | $30 | $12.59 | +138.28% | 1 | Jan 9, 2026 | |
| HNGE Hinge Health | Initiates: Overweight | $68 | $45.74 | +48.67% | 1 | Jan 9, 2026 | |
| OMDA Omada Health | Initiates: Equal-Weight | $17 | $13.23 | +28.54% | 1 | Jan 9, 2026 | |
| OMCL Omnicell | Maintains: Overweight | $43 → $52 | $41.24 | +26.09% | 18 | Jan 5, 2026 | |
| VEEV Veeva Systems | Maintains: Overweight | $341 → $333 | $185.45 | +79.56% | 9 | Nov 25, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $1.79 | +179.33% | 7 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $9 | $5.14 | +75.03% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $2.14 | +227.87% | 8 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $125 | $81.83 | +52.76% | 9 | Feb 26, 2025 |
Teladoc Health
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $8 → $6
Current: $5.24
Upside: +14.50%
Claritev
Feb 24, 2026
Maintains: Equal-Weight
Price Target: $33 → $30
Current: $17.57
Upside: +70.75%
Waystar Holding
Feb 19, 2026
Maintains: Overweight
Price Target: $41 → $36
Current: $26.44
Upside: +36.18%
Doximity
Feb 6, 2026
Maintains: Overweight
Price Target: $55 → $45
Current: $26.25
Upside: +71.43%
Phreesia
Jan 9, 2026
Initiates: Overweight
Price Target: $30
Current: $12.59
Upside: +138.28%
Hinge Health
Jan 9, 2026
Initiates: Overweight
Price Target: $68
Current: $45.74
Upside: +48.67%
Omada Health
Jan 9, 2026
Initiates: Equal-Weight
Price Target: $17
Current: $13.23
Upside: +28.54%
Omnicell
Jan 5, 2026
Maintains: Overweight
Price Target: $43 → $52
Current: $41.24
Upside: +26.09%
Veeva Systems
Nov 25, 2025
Maintains: Overweight
Price Target: $341 → $333
Current: $185.45
Upside: +79.56%
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $1.79
Upside: +179.33%
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $5.14
Upside: +75.03%
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.14
Upside: +227.87%
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $81.83
Upside: +52.76%